On the contrary, in breast cancer cells lines overexpressing HER2 (BT-474 and SKBR3), 10 μM oleic acid decreased the HER2 expression and synergistically enhanced the anti-proliferative effect of the HER2 inhibitor trastuzumab [110,111]. The gene discussed is ERBB2; the disease is breast cancer.